|
|
|
|
|
|
| Drägerwerk AG — Lübeck, Oct. 28, 2004 — Based on the figures for the first nine months of 2004 the Dräger Medical has reduced its sales forecast for 2004 from originally 1,090 million EUR to between 1,000 Mio EUR and 1,050 Mio EUR. As a result, the operating EBIT of Dräger Medical will probably decrease from 122 million EUR to around 100 million EUR. |
|
| The reason for this deviation is that the positive effects of the restructuring of the US sales organization will be delayed and that the shortfall accumulated up to the third quarter cannot be compensated within the division. At the same time the strong ongoing consolidation in the market has led to substantial price pressure in some product segments. |
|
| The Dräger Group now targets Group net sales of around 1,500 million EUR to 1,550 million EUR (planned 1,567 million EUR) and an operating EBIT (before one-time expenses) in the range of the budgeted 124 million EUR. The budgeted net income (before minorities) of 46 million EUR is expected to be achieved.
|
|
| Additional one-time expenses may result from an analysis of the Lübeck site currently going on within Dräger Medical. If these expenses will arise and in which amount can only be determined after the respective decisions on the future location have been made. |
|
| The detailed quarterly report will be published on November 11, 2004. |
|
| This press release contains statements as to the future trends within the Dräger Group. Such statements cannot be guaranteed since they are based on assumptions and estimates that are linked to certain risks and uncertainties. |
|
Contact
Corporate Communications:
Dr. Welf Böttcher, Drägerwerk AG, Tel. 0451-882-2201,
welf.boettcher@draeger.com
Investor Relations:
Vanina Herbst, Drägerwerk AG, Tel. 0451-882-2685,
vanina.herbst@draeger.com
|
|
|
|
|
|
|
|
|
|
(c) Drägerwerk AG & Co. KGaA, 2007 |
|
 |
|
|
|
|
|
 |
|
